Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

News

Lilly to buy gene-editing partner Verve

Digest more
 · 18h · on MSN
Lilly to buy gene-editing partner Verve for up to $1.3 billion in cardiac care push
Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, to boost its pipeline of experimental medicines beyond its blockbuster weight-loss and diabetes drugs.

Continue reading

 · 12h · on MSN
Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs
 · 18h
Eli Lilly strikes deal to buy Crispr gene-editing biotech Verve
16hon MSN
Eli Lilly’s $1.3 Billion Bid Sends Verve Therapeutics Stock Soaring. What to Know.
Lilly confirmed it would buy a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.
15hon MSN
Why Verve Therapeutics Stock Is Skyrocketing Today
Eli Lilly plans to acquire Verve for up to $1.3 billion. Shares of Verve Therapeutics (NASDAQ: VERV) were skyrocketing 75.7% ...
uDiscoverMusic
11d
The Verve’s ‘Urban Hymns’ Is Returning To Vinyl
The Verve’s founder and lead singer, Richard Ashcroft, became a solo act in 2000. He recently released the single “Lover,” ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy